• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

样本采集与储存对血小板第4因子-肝素抗体检测的影响

Influence of sample collection and storage on the detection of platelet factor 4-heparin antibodies.

作者信息

Krakow Elizabeth F, Goudar Ranjit, Petzold Elizabeth, Suvarna Shayela, Last Michael, Welsby Ian J, Ortel Thomas L, Arepally Gowthami M

机构信息

Department of Medicine, Duke University Medical Center, Durham, NC, USA.

出版信息

Am J Clin Pathol. 2007 Jul;128(1):150-5. doi: 10.1309/RFQK57F5QMURQ1HY.

DOI:10.1309/RFQK57F5QMURQ1HY
PMID:17580283
Abstract

Heparin-induced thrombocytopenia is a life threatening thrombotic disorder caused by antibodies to platelet factor 4 (PF4) and heparin. Commercial immunoassays are frequently used for the detection of PF4-heparin antibodies, and several studies have reported that higher antibody titers are more frequently associated with adverse events. It is not known if conditions involving sample preparation and/or storage affect the operational characteristics of PF4-heparin immunoassays. We compared the detection of PF4-heparin antibodies from 48 patient samples collected concordantly in serum separator tubes or tubes containing EDTA or sodium citrate. We also examined the effects of extended sample storage on whole blood collected in serum separator, EDTA, or citrate tubes at 4 degrees C for up to 96 hours on antibody detection. We noted that serum or plasma anticoagulated with sodium citrate or EDTA yielded comparable results. In addition, we could not demonstrate any significant sample deterioration after storage at 4 degrees C in any medium for up to 4 days. These findings suggest that PF4-heparin antibodies are largely insensitive to the effects of sample preparation and storage.

摘要

肝素诱导的血小板减少症是一种由针对血小板因子4(PF4)和肝素的抗体引起的危及生命的血栓形成性疾病。商业免疫测定法常用于检测PF4-肝素抗体,多项研究报告称,较高的抗体滴度更常与不良事件相关。尚不清楚涉及样本制备和/或储存的条件是否会影响PF4-肝素免疫测定的操作特性。我们比较了从在血清分离管或含有乙二胺四乙酸(EDTA)或柠檬酸钠的试管中一致采集的48份患者样本中检测PF4-肝素抗体的情况。我们还研究了将血清分离管、EDTA管或柠檬酸钠管中采集的全血在4℃下延长样本储存长达96小时对抗体检测的影响。我们注意到,用柠檬酸钠或EDTA抗凝的血清或血浆产生了可比的结果。此外,我们无法证明在任何培养基中于4℃储存长达4天后样本有任何明显变质。这些发现表明,PF4-肝素抗体在很大程度上对样本制备和储存的影响不敏感。

相似文献

1
Influence of sample collection and storage on the detection of platelet factor 4-heparin antibodies.样本采集与储存对血小板第4因子-肝素抗体检测的影响
Am J Clin Pathol. 2007 Jul;128(1):150-5. doi: 10.1309/RFQK57F5QMURQ1HY.
2
Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.心脏手术前后肝素/血小板第4因子抗体的患病率
Ann Thorac Surg. 2007 Feb;83(2):592-7. doi: 10.1016/j.athoracsur.2006.09.040.
3
Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.抗血小板因子4/肝素抗体患者的血栓形成事件
Heart. 2009 Aug;95(16):1350-4. doi: 10.1136/hrt.2008.160549. Epub 2009 May 28.
4
Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems.抗肝素/PF4抗体的标题以及体内凝血和纤溶系统的激活程度。
Thromb Haemost. 2004 Feb;91(2):276-82. doi: 10.1160/TH03-07-0454.
5
Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.肝素治疗后肝素/血小板第4因子抗体的形成:时间因素及长期随访
Am Heart J. 2009 Mar;157(3):589-95. doi: 10.1016/j.ahj.2008.11.007. Epub 2009 Jan 13.
6
The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.慢性血液透析患者中血小板因子4-肝素复合物抗体的患病率及其与血管通路血栓形成的关联。
Thromb Res. 2007;120(2):215-20. doi: 10.1016/j.thromres.2006.09.014. Epub 2006 Nov 13.
7
Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.接受心脏导管插入术患者中肝素诱导的血小板减少症的患病率。
Am Heart J. 2006 Aug;152(2):290.e1-7. doi: 10.1016/j.ahj.2006.04.028.
8
Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.接受心脏导管插入术患者抗肝素/血小板因子4抗体滴度升高的预测因素。
Am J Cardiol. 2006 Aug 1;98(3):419-21. doi: 10.1016/j.amjcard.2006.02.048. Epub 2006 Jun 12.
9
Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.通过电荷中和使两个血小板因子4四聚体紧密靠近,形成了被肝素诱导的血小板减少症(HIT)抗体识别的抗原。
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2386-93. doi: 10.1161/01.ATV.0000238350.89477.88. Epub 2006 Jul 27.
10
A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide.胰岛素样生长因子-I和III型前胶原肽分析前储存条件的测定。
Growth Horm IGF Res. 2009 Feb;19(1):43-50. doi: 10.1016/j.ghir.2008.06.001. Epub 2008 Jul 9.

引用本文的文献

1
Platelet factor 4/heparin antibodies in blood bank donors.血小板因子 4/肝素抗体在血库供者中的情况。
Am J Clin Pathol. 2010 Nov;134(5):774-80. doi: 10.1309/AJCPG0MNR5NGKNFX.
2
Platelet factor 4/heparin antibody (IgG/M/A) in healthy subjects: a literature analysis of commercial immunoassay results.健康受试者中的血小板第4因子/肝素抗体(IgG/M/A):商业免疫测定结果的文献分析
J Thromb Thrombolysis. 2008 Aug;26(1):55-61. doi: 10.1007/s11239-008-0217-y. Epub 2008 Mar 28.